Nur77: a potential therapeutic target in cancer
- 26 April 2012
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Targets
- Vol. 16 (6) , 573-585
Abstract
Introduction: The orphan nuclear receptor Nur77 (also known as NR4A1, NGFIB, TR3, TIS1, NAK-1, or N10) is a unique transcription factor encoded by an immediate early gene. Nur77 signaling is deregulated in many cancers and constitutes an important molecule for drug targeting. Areas covered: Nur77 as a versatile transcription factor that displays distinct dual roles in cell proliferation and apoptosis. In addition, several recent insights into Nur77's non-genomic signaling through its physical interactions with various signaling proteins and its phosphorylation-dependent regulation will be highlighted. The possible mechanisms by which Nur77 supports carcinogenesis and specific examples in different human cancers will be summarized. Different approaches to target Nur77 using mimetics, natural products, and synthetic compounds are also described. Expert opinion: These latest findings shed light on the novel roles of Nur77 as an exploitable target for new cancer therapeutics. Further work which focuses on a more complete understanding of the Nur77 interactome as well as how the different networks of Nur77 functional interactions are orchestrated in a stimulus or context-specific way will aid the development of more selective, non-toxic approaches for targeting Nur77 in future.Keywords
This publication has 113 references indexed in Scilit:
- Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletionProceedings of the National Academy of Sciences, 2012
- Orphan nuclear transcription factor TR3/Nur77 regulates microvessel permeability by targeting endothelial nitric oxide synthase and destabilizing endothelial junctionsProceedings of the National Academy of Sciences, 2011
- The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C− monocytesNature Immunology, 2011
- ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cellsBiochemical Pharmacology, 2011
- Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor‐1 in thymocytes undergoing apoptosisEuropean Journal of Immunology, 2010
- Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cellsBiochemical Pharmacology, 2010
- A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a KillerCancer Cell, 2008
- p53 mediates the negative regulation of MDM2 by orphan receptor TR3The EMBO Journal, 2006
- Two Functional Modes of a Nuclear Receptor-Recruited Arginine Methyltransferase in Transcriptional ActivationMolecular Cell, 2006
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002